AnalystsKelsey GoodwinKelsey Goodwin's Stock Forecasts
AnalystsKelsey Goodwin
Sectors:
Industries:
Analyst Ranking
Bottom 13%
#4248 out of 4870 analysts
Average Return
-21.04%
Win Rate
20%2 out of 10
Risk vs Reward
Poor
Good
Kelsey Goodwin's 5 best and worst ratings
Kelsey Goodwin Analyst Color
Get additional color on Kelsey Goodwin's coverage of popular stocks
Kelsey Goodwin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Century Therapeutics IncIPSC | 2 | Strong Buy | $5.00 | +800.90% | Maintains | a month ago |
Genelux CorpGNLX | 1 | Strong Buy | $8.00 | +229.90% | Initiates Coverage On | 6 months ago |
Nuvalent IncNUVL | 2 | Strong Buy | $105.00 | +37.74% | Maintains | 8 months ago |
Urogen Pharma LtdURGN | 1 | Strong Buy | $40.00 | +250.57% | Initiates Coverage On | 8 months ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $26.00 | N/A | Maintains | 2 years ago |
Arcellx IncACLX | 2 | Strong Buy | $58.00 | N/A | Maintains | 2 years ago |
Legend Biotech CorpLEGN | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Iovance Biotherapeutics IncIOVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.